SCHEMBL20219599

SCHEMBL20219599

CCCCNc1ncncc1OCc1cccc(C(=O)c2ccccc2)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MRGPRX4 Q96LA9 5/20 0.45
▸ NPC1 O15118 2/20 0.44
▸ RAB9A P51151 2/20 0.44
▸ SMN1; SMN2 Q16637 2/20 0.44
▸ CYP1A2 P05177 2/20 0.44
▸ CYP2D6 P10635 1/20 0.44
▸ VNN1 O95497 4/20 0.42
▸ ALKBH1 Q13686 1/20 0.41
▸ CYP3A4 P08684 1/20 0.41
▸ TLR8 Q9NR97 2/20 0.41
▸ TLR7 Q9NYK1 2/20 0.41
▸ HDAC3 O15379 1/20 0.41
▸ SRD5A2 P31213 1/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ MITF O75030 1/20 0.40
▸ TP53 P04637 1/20 0.40
▸ HPGD P15428 1/20 0.40
▸ XBP1 P17861 1/20 0.40
▸ NFKB1 P19838 1/20 0.40
▸ NFKB2 Q00653 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20219392 0.85 CYP1A2 (0.46) MRGPRX4NPC1RAB9ASMN1; SMN2CYP1A2
SCHEMBL15469973 0.84 CYP1A2 (0.54) MRGPRX4NPC1RAB9ASMN1; SMN2CYP1A2
SCHEMBL23472599 0.74 CYP1A2 (0.44) SMN1; SMN2CYP1A2CYP2D6CYP3A4TLR8
SCHEMBL13195812 0.73 TLR7 (0.59) MRGPRX4NPC1RAB9ASMN1; SMN2CYP1A2
SCHEMBL23472368 0.73 CYP1A2 (0.54) CYP1A2CYP2D6CYP3A4TLR8TLR7
SCHEMBL23472382 0.72 TLR8 (0.43) NPC1RAB9ASMN1; SMN2CYP1A2CYP2D6
SCHEMBL20219500 0.71 CYP1A2 (0.47) SMN1; SMN2CYP1A2CYP2D6CYP3A4TLR8
SCHEMBL13195688 0.70 CYP1A2 (0.51) NPC1RAB9ASMN1; SMN2CYP1A2CYP2D6
SCHEMBL23472224 0.70 GPBAR1 (0.49) SMN1; SMN2CYP1A2CYP2D6CYP3A4TLR7
SCHEMBL23472700 0.69 LMNA (0.38) NPC1RAB9ASMN1; SMN2CYP1A2CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3330257-A1 PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF VIRAL INFECTIONS Janssen Sciences Ireland UC (IE) 2018-06-06 — — EP disclosed
Send feedback